ArticleInternational journal of nanomedicine2025
Gold@Mesoporous Polydopamine Nanocomposite Hydrogel Loaded with Estrogen for the Treatment of Skin Photoaging.
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reactive oxygen species in skin diseases: pathogenic mechanisms and nanomaterial-based therapeutic strategies.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Topical application of 17β-estradiol (E2) has been shown to improve various hallmark features of skin aging, including enhancing skin elasticity and hydration, reducing wrinkles, and promoting collagen synthesis. However, the role of estrogen in UVB-induced photoaging of the skin remains unclear. Furthermore, E2's clinical application is limited by issues such as bioavailability and potential adverse effects. Therefore, this study aims to explore the role of E2 in UVB-induced skin photoaging and to prepare a gold (Au)@mesoporous polydopamine (mPDA)-hyaluronic acid (HA)/carboxymethyl chitosan (CMCS) nanoparticle composite hydrogel (Au/E2@mPDA-HCG) for the treatment of skin photoaging. Methods: This study successfully fabricated mPDA with a well-defined mesoporous structure and incorporated Au NPs into the mesopores of mPDA using an in situ growth method, thereby constructing Au@mPDA NPs loaded with E2. Subsequently, the Au/E2@mPDA NPs were embedded into a HA/CMCS hydrogel to develop the Au/E2@mPDA-HCG nanoparticle composite hydrogel. The composite hydrogel was characterized through in vitro and in vivo experiments, and its efficacy in improving skin photoaging was evaluated. Results: This study revealed that estrogen deficiency significantly exacerbates UVB-induced skin photoaging, likely through mechanisms closely associated with increased oxidative stress and reduced collagen production. Moreover, the Au/E2@mPDA-HCG nanoparticle composite hydrogel demonstrated favorable morphological characteristics and biocompatibility. In vitro and in vivo experimental results indicated that this composite hydrogel effectively enhanced the therapeutic efficacy of E2 in treating skin photoaging, as evidenced by its significant mitigation of oxidative stress and inflammatory responses, along with the promotion of collagen synthesis. Conclusion: In conclusion, this study suggests that the combination of E2 with Au@mPDA@HCG nanocomposite hydrogel offers a promising therapeutic strategy for UVB-induced skin photoaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.